Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study

Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study

Abstract Introduction Moderate to severe ocular surface disease (OSD) can substantially impair quality of life in patients with lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy. Although multiple studies have reported cases of OSD associated with EG...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu-Ting Tsao, Eugene Yu-Chuan Kang, Chiao-En Wu, Ning Hung, Hung-Chi Chen, Ching-Hsi Hsiao
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-07-01
Series:Ophthalmology and Therapy
Subjects:
Conjunctivitis
Corneal ulcer
Dry eye disease
Epidermal growth factor receptor inhibitor
Lung neoplasms
Keratitis
Online Access:https://doi.org/10.1007/s40123-025-01200-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40123-025-01200-4

Similar Items